Beaird Harris Wealth Management’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Beaird Harris Wealth Management’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-168	Closed	–	–	672
2022 Q1	$0	Hold	168	–	–	﹤0.01%	774
2021 Q4	$0	Buy	+168	New	+$684	﹤0.01%	685

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Beaird Harris Wealth Management's KLDO Position: Q2 2022 in Review

Beaird Harris Wealth Management sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 168 shares.

Beaird Harris Wealth Management first reported a position in KLDO in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Beaird Harris Wealth Management reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Beaird Harris Wealth Management sold 168 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022.
Beaird Harris Wealth Management first reported a position in Kaleido Biosciences, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Beaird Harris Wealth Management's Kaleido Biosciences, Inc. Common Stock position peaked at $0 in Q1 2022.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.